Analysis: Experts question reliance on monkeypox vaccine with little data, short supply

Analysis: Experts question reliance on monkeypox vaccine with little data, short supply A reliance on vaccines in short supply and questions over their best use are hampering efforts to curb the global spread of monkeypox which has hit dozens of countries for the first time, health officials say. Jennifer Rigby,Natalie Grover Reuters

...

There are just 1.5 million vials of Bavarian Nordic's (BAVA.CO) monkeypox vaccine either administered or currently available in the ten worst-affected countries, which account for nearly 90% of all cases. The vast majority of doses are in the United States. The figures are based on a Reuters tally of government statements, and highlight the extent of the global supply gap for the first time.

...